Davita Healthcare Partners Inc (DVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 427,410 | 863,330 | 757,201 | 641,237 | 573,395 |
| Depreciation Amortization | 638,024 | 590,935 | 528,119 | 343,908 | 267,315 |
| Income taxes - deferred | 61,744 | 210,955 | -25,380 | 43,765 | 53,438 |
| Accounts receivable | -202,867 | -40,676 | -59,640 | -47,673 | -88,848 |
| Accounts payable and accrued liabilities | 30,998 | -2,956 | 16,666 | 40,878 | 84,400 |
| Other Working Capital | 59,843 | -29,995 | 74,181 | -34,148 | 175,132 |
| Other Operating Activity | 542,048 | -132,186 | 482,194 | 112,881 | 115,214 |
| Operating Cash Flow | $1,557,200 | $1,459,407 | $1,773,341 | $1,100,848 | $1,180,046 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -79,250 | -337,521 | -7,950 | 10,388 | 42,873 |
| PPE Investments | -688,283 | -632,539 | -555,339 | -546,587 | -324,973 |
| Net Acquisitions | -96,469 | -272,094 | -310,394 | -4,294,077 | -1,077,442 |
| Purchase Of Investment | -17,911 | -35,382 | -1,305 | -1,352 | -40,026 |
| Purchase Sale Intangibles | N/A | -1,018 | -2,391 | -830 | N/A |
| Other Investing Activity | 129 | -193 | -1,894 | -822 | 340 |
| Investing Cash Flow | $-881,784 | $-1,277,729 | $-876,882 | $-4,832,450 | $-1,399,228 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 54,541,990 | 60,038,510 | 66,286,090 | 43,248,180 | 36,395,110 |
| Debt Repayment | -53,998,960 | -60,046,490 | -66,723,380 | -39,286,030 | -36,267,450 |
| Common Stock Issued | 26,155 | 19,500 | 16,423 | 6,647 | 11,316 |
| Common Stock Repurchased | -549,935 | N/A | N/A | N/A | -323,348 |
| Other Financing Activity | -158,220 | -176,499 | -62,124 | -96,413 | -62,811 |
| Financing Cash Flow | $-138,970 | $-164,979 | $-482,991 | $3,872,384 | $-247,183 |
| Exchange Rate Effect | -2,571 | 2,293 | -967 | -786 | N/A |
| Beginning Cash Position | 736,897 | 946,249 | 533,748 | 393,752 | 860,117 |
| End Cash Position | 1,244,917 | 965,241 | 946,249 | 533,748 | 393,752 |
| Net Cash Flow | $508,020 | $18,992 | $412,501 | $139,996 | $-466,365 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,557,200 | 1,459,407 | 1,773,341 | 1,100,848 | 1,180,046 |
| Capital Expenditure | -707,998 | -641,330 | -617,597 | -550,146 | -400,156 |
| Free Cash Flow | 849,202 | 818,077 | 1,155,744 | 550,702 | 779,890 |